vs
Acadia Healthcare Company, Inc.（ACHC）与MAXIMUS, INC.（MMS）财务数据对比。点击上方公司名可切换其他公司
MAXIMUS, INC.的季度营收约是Acadia Healthcare Company, Inc.的1.6倍（$1.3B vs $829.0M），MAXIMUS, INC.净利率更高（30.2% vs 0.5%，领先29.6%），Acadia Healthcare Company, Inc.同比增速更快（7.5% vs -2.8%），过去两年Acadia Healthcare Company, Inc.的营收复合增速更高（2.0% vs -0.3%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
MAXIMUS是美国一家政府服务企业，业务覆盖美国、加拿大、英国等国家，为医疗补助、联邦医疗保险、医改、就业帮扶、学生贷款服务等各类政府项目提供行政及配套服务。公司总部位于弗吉尼亚州泰森斯，现有员工3.96万名，2024财年营收达53亿美元。
ACHC vs MMS — 直观对比
营收规模更大
MMS
是对方的1.6倍
$829.0M
营收增速更快
ACHC
高出10.3%
-2.8%
净利率更高
MMS
高出29.6%
0.5%
两年增速更快
ACHC
近两年复合增速
-0.3%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $829.0M | $1.3B |
| 净利润 | $4.5M | $394.0M |
| 毛利率 | — | 26.2% |
| 营业利润率 | — | 11.4% |
| 净利率 | 0.5% | 30.2% |
| 营收同比 | 7.5% | -2.8% |
| 净利润同比 | -50.8% | -4.1% |
| 每股收益（稀释后） | $0.05 | $7.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCMMS
| Q1 26 | $829.0M | $1.3B | ||
| Q4 25 | $821.5M | $1.3B | ||
| Q3 25 | $851.6M | $1.3B | ||
| Q2 25 | $869.2M | $1.3B | ||
| Q1 25 | $770.5M | $1.4B | ||
| Q4 24 | $774.2M | $1.4B | ||
| Q3 24 | $815.6M | $1.3B | ||
| Q2 24 | $796.0M | $1.3B |
净利润ACHCMMS
| Q1 26 | $4.5M | $394.0M | ||
| Q4 25 | $-1.2B | $93.9M | ||
| Q3 25 | $36.2M | $75.3M | ||
| Q2 25 | $30.1M | $106.0M | ||
| Q1 25 | $8.4M | $96.6M | ||
| Q4 24 | $32.6M | $41.2M | ||
| Q3 24 | $68.1M | $72.5M | ||
| Q2 24 | $78.5M | $89.8M |
毛利率ACHCMMS
| Q1 26 | — | 26.2% | ||
| Q4 25 | — | 23.7% | ||
| Q3 25 | — | 25.3% | ||
| Q2 25 | — | 26.7% | ||
| Q1 25 | — | 24.9% | ||
| Q4 24 | — | 21.5% | ||
| Q3 24 | — | 22.9% | ||
| Q2 24 | — | 25.3% |
营业利润率ACHCMMS
| Q1 26 | — | 11.4% | ||
| Q4 25 | -142.4% | 10.9% | ||
| Q3 25 | 4.7% | 9.3% | ||
| Q2 25 | 5.8% | 12.3% | ||
| Q1 25 | 1.7% | 11.2% | ||
| Q4 24 | 4.9% | 6.2% | ||
| Q3 24 | 12.1% | 8.5% | ||
| Q2 24 | 13.4% | 10.8% |
净利率ACHCMMS
| Q1 26 | 0.5% | 30.2% | ||
| Q4 25 | -143.3% | 7.0% | ||
| Q3 25 | 4.3% | 5.7% | ||
| Q2 25 | 3.5% | 7.9% | ||
| Q1 25 | 1.1% | 7.1% | ||
| Q4 24 | 4.2% | 2.9% | ||
| Q3 24 | 8.4% | 5.5% | ||
| Q2 24 | 9.9% | 6.8% |
每股收益（稀释后）ACHCMMS
| Q1 26 | $0.05 | $7.27 | ||
| Q4 25 | $-12.98 | $1.70 | ||
| Q3 25 | $0.40 | $1.27 | ||
| Q2 25 | $0.33 | $1.86 | ||
| Q1 25 | $0.09 | $1.69 | ||
| Q4 24 | $0.36 | $0.69 | ||
| Q3 24 | $0.74 | $1.18 | ||
| Q2 24 | $0.85 | $1.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $158.5M | $157.5M |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $2.0B | $1.7B |
| 总资产 | $5.5B | $4.2B |
| 负债/权益比越低杠杆越低 | 1.29× | — |
8季度趋势，按日历期对齐
现金及短期投资ACHCMMS
| Q1 26 | $158.5M | $157.5M | ||
| Q4 25 | $133.2M | $137.6M | ||
| Q3 25 | $118.7M | $222.4M | ||
| Q2 25 | $131.4M | $59.8M | ||
| Q1 25 | $91.2M | $108.1M | ||
| Q4 24 | $76.3M | $72.7M | ||
| Q3 24 | $82.1M | $183.1M | ||
| Q2 24 | $77.2M | $102.8M |
总债务ACHCMMS
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
股东权益ACHCMMS
| Q1 26 | $2.0B | $1.7B | ||
| Q4 25 | $1.9B | $1.7B | ||
| Q3 25 | $3.1B | $1.7B | ||
| Q2 25 | $3.1B | $1.8B | ||
| Q1 25 | $3.0B | $1.7B | ||
| Q4 24 | $3.1B | $1.6B | ||
| Q3 24 | $3.0B | $1.8B | ||
| Q2 24 | $3.0B | $1.8B |
总资产ACHCMMS
| Q1 26 | $5.5B | $4.2B | ||
| Q4 25 | $5.5B | $4.2B | ||
| Q3 25 | $6.4B | $4.1B | ||
| Q2 25 | $6.3B | $4.5B | ||
| Q1 25 | $6.1B | $4.2B | ||
| Q4 24 | $6.0B | $4.1B | ||
| Q3 24 | $5.9B | $4.1B | ||
| Q2 24 | $5.7B | $4.0B |
负债/权益比ACHCMMS
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.5M | — |
| 自由现金流经营现金流 - 资本支出 | — | $450.0M |
| 自由现金流率自由现金流/营收 | — | 34.5% |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 13.78× | — |
| 过去12个月自由现金流最近4个季度 | — | $643.0M |
8季度趋势，按日历期对齐
经营现金流ACHCMMS
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $-244.4M | ||
| Q3 25 | $73.2M | $649.4M | ||
| Q2 25 | $133.5M | $-182.7M | ||
| Q1 25 | $11.5M | $42.7M | ||
| Q4 24 | $116.7M | $-80.0M | ||
| Q3 24 | $163.1M | $163.8M | ||
| Q2 24 | $171.1M | $199.3M |
自由现金流ACHCMMS
| Q1 26 | — | $450.0M | ||
| Q4 25 | $-179.5M | $-250.7M | ||
| Q3 25 | $-63.0M | $641.8M | ||
| Q2 25 | $-34.2M | $-198.2M | ||
| Q1 25 | $-163.2M | $25.5M | ||
| Q4 24 | $-86.8M | $-103.0M | ||
| Q3 24 | $-27.1M | $131.9M | ||
| Q2 24 | $16.9M | $164.6M |
自由现金流率ACHCMMS
| Q1 26 | — | 34.5% | ||
| Q4 25 | -21.8% | -18.6% | ||
| Q3 25 | -7.4% | 48.7% | ||
| Q2 25 | -3.9% | -14.7% | ||
| Q1 25 | -21.2% | 1.9% | ||
| Q4 24 | -11.2% | -7.3% | ||
| Q3 24 | -3.3% | 10.0% | ||
| Q2 24 | 2.1% | 12.5% |
资本支出强度ACHCMMS
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 0.5% | ||
| Q3 25 | 16.0% | 0.6% | ||
| Q2 25 | 19.3% | 1.1% | ||
| Q1 25 | 22.7% | 1.3% | ||
| Q4 24 | 26.3% | 1.6% | ||
| Q3 24 | 23.3% | 2.4% | ||
| Q2 24 | 19.4% | 2.6% |
现金转化率ACHCMMS
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | -2.60× | ||
| Q3 25 | 2.02× | 8.63× | ||
| Q2 25 | 4.43× | -1.72× | ||
| Q1 25 | 1.37× | 0.44× | ||
| Q4 24 | 3.58× | -1.94× | ||
| Q3 24 | 2.39× | 2.26× | ||
| Q2 24 | 2.18× | 2.22× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
MMS
暂无分部数据
